Lissa K. Magloire
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Lissa K. Magloire has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
Catalin S. Buhimschi
2 shared publicationsChristian M. Pettker
2 shared publicationsAnna K. Sfakianaki
1 shared publicationBenjamin D. Hamar
1 shared publicationEdmund F. Funai
1 shared publication- Irina Alexandra Buhimschi
Department of Obstetrics and Gynecology, University of Illinois Chicago, Chicago, IL, 60612, USA
1 shared publication
Latest Publications
- 1 October 2006
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 195 (4) , 1045-1052
Lactate dehydrogenase isoform activity mapping in patients with intra-amniotic infection
- 1 October 2006
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 195 (4) , 1045-1052
Lactate dehydrogenase isoform activity mapping in patients with intra-amniotic infection
- 1 September 2006
- Published by Wolters Kluwer Health in Obstetrics & Gynecology
- Vol. 108 (3) , 743-745
Burkitt’s Lymphoma of the Ovary in Pregnancy
Burkitt's lymphoma is a rapidly growing and, if untreated, rapidly fatal tumor derived from B-lymphocytes. The occurrence of Burkitt's lymphoma during pregnancy is rare. A patient with Burkitt's lymphoma presented at 12 weeks of gestation with abdominal and tooth pain. An 11 x 11 x 15 cm mass was seen on abdominal/pelvic ultrasonogram. She underwent a left salpingo-oophorectomy with removal of the mass, as well as a tooth extraction. The pathology examination confirmed lymphoma in the left ovary and in the tissue surrounding the extracted tooth. After surgical resection, she was treated with multiagent chemotherapy beginning at 13 4/7 weeks of gestation. At 39 weeks, she delivered a viable female infant weighing 2,270 g. The finding of an adnexal mass in conjunction with head and neck symptoms led to consideration of Burkitt's lymphoma. Prompt treatment with multiagent chemotherapy should be considered for pregnant patients with Burkitt's lymphoma.
- 1 September 2006
- Published by Wolters Kluwer Health in Obstetrics & Gynecology
- Vol. 108 (3) , 743-745
Burkitt’s Lymphoma of the Ovary in Pregnancy
Burkitt's lymphoma is a rapidly growing and, if untreated, rapidly fatal tumor derived from B-lymphocytes. The occurrence of Burkitt's lymphoma during pregnancy is rare. A patient with Burkitt's lymphoma presented at 12 weeks of gestation with abdominal and tooth pain. An 11 x 11 x 15 cm mass was seen on abdominal/pelvic ultrasonogram. She underwent a left salpingo-oophorectomy with removal of the mass, as well as a tooth extraction. The pathology examination confirmed lymphoma in the left ovary and in the tissue surrounding the extracted tooth. After surgical resection, she was treated with multiagent chemotherapy beginning at 13 4/7 weeks of gestation. At 39 weeks, she delivered a viable female infant weighing 2,270 g. The finding of an adnexal mass in conjunction with head and neck symptoms led to consideration of Burkitt's lymphoma. Prompt treatment with multiagent chemotherapy should be considered for pregnant patients with Burkitt's lymphoma.